EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer

P Cornford, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Application of nanomaterials in biomedical imaging and cancer therapy

S Siddique, JCL Chow - Nanomaterials, 2020 - mdpi.com
Nanomaterials, such as nanoparticles, nanorods, nanosphere, nanoshells, and nanostars,
are very commonly used in biomedical imaging and cancer therapy. They make excellent …

Clinical and biological features of neuroendocrine prostate cancer

Y Yamada, H Beltran - Current oncology reports, 2021 - Springer
Abstract Purpose of Review Neuroendocrine prostate cancer (NEPC) is an aggressive
histologic subtype of prostate cancer that most commonly arises in later stages of prostate …

Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy

O Keinänen, K Fung, JM Brennan… - Proceedings of the …, 2020 - National Acad Sciences
Over the past decade, theranostic imaging has emerged as a powerful clinical tool in
oncology for identifying patients likely to respond to targeted therapies and for monitoring …

Bone metastases

RE Coleman, J Brown, I Holen - Abeloff's clinical oncology, 2020 - Elsevier
Bone metastasis is a major cause of morbidity in persons with cancer. Complications include
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …

Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology

MSO Pijeira, H Viltres, J Kozempel, M Sakmár… - EJNMMI …, 2022 - Springer
Background Recent advances in nanotechnology have offered new hope for cancer
detection, prevention, and treatment. Nanomedicine, a term for the application of …

[HTML][HTML] Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities

PI Siafaka, NÜ Okur, ID Karantas, ME Okur… - Asian Journal of …, 2021 - Elsevier
In the last decade, the use of nanotheranostics as emerging diagnostic and therapeutic tools
for various diseases, especially cancer, is held great attention. Up to date, several …

An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications

J Millul, G Bassi, J Mock, A Elsayed… - Proceedings of the …, 2021 - National Acad Sciences
We describe the development of OncoFAP, an ultra-high-affinity ligand of fibroblast
activation protein (FAP) for targeting applications with pan-tumoral potential. OncoFAP binds …

Carbon-based nanomaterials for targeted cancer nanotherapy: Recent trends and future prospects

M Sajjadi, M Nasrollahzadeh, B Jaleh… - Journal of Drug …, 2021 - Taylor & Francis
Carbon-based nanomaterials are becoming attractive materials due to their unique
structural dimensions and promising mechanical, electrical, thermal, optical and chemical …

Expanding theranostic radiopharmaceuticals for tumor diagnosis and therapy

C Barca, CM Griessinger, A Faust, D Depke, M Essler… - Pharmaceuticals, 2021 - mdpi.com
Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and
molecular imaging (MI), including positron emission tomography (PET), single-photon …